Vanguard Portfolio Management »

Immix Biopharma shares owned by Vanguard Portfolio Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Vanguard Portfolio Management from 13F filings

Historical chart of Vanguard Portfolio Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Vanguard Portfolio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 284k 10.31

More positions owned by Vanguard Portfolio Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Exxon Mobil Corporation (XOM)

View all positions for Vanguard Portfolio Management

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma